Microsoft helps Wall St. to another day of record highs

UBS Raises Price Target on Morgan Stanley (MS) Following 2Q

UBS reiterated a Buy rating on Morgan Stanley (NYSE: MS), and raised the price target to $34.00 (from $32.00), following the company's 2Q earnings report.

Analyst Brennan Hawken commented, "MS's FICC results certainly were a positive surprise but given the ongoing restructuring we caution against annualizing... More

Needham & Company Remains Bullish on Intel (INTC) Following 2Q Results

Needham & Company reiterated a Buy rating and $38.00 price target on Intel (NASDAQ: INTC) following the company's 2Q earnings report. Intel reported revenue of $13.5bn, in-line with estimates. Non-gaap EPS of $0.59 beat $0.53 estimates. EPS included a $0.05 benefit from higher than expected interest and... More

Baird Remains Bullish on Intel (INTC) Following In-Line 2Q Report

Baird reiterated an Outperform rating and $38.00 price target on Intel (NASDAQ: INTC) following the company's 2Q earnings report. INTC reported EPS of $0.27, in line with consensus. Revenue of $13.5 billion was in line with the midpoint of guidance of $13.0-$14.0 billion. Management guided 3Q16 revenue midpoint... More

Microsoft (MSFT) PT Raised to $65 at FBN Securities Following Solid Q4

FBN Securities analyst Shebly Seyrafi raised its price target on Microsoft (NASDAQ: MSFT) to $65.00 (from $55.00) following strong Q4 results. The firm maintained a Outperform rating.

Seyrafi commented, " We retain our Outperform rating and raise our PT from $55 to $65. The company continues to grow well in the... More

Intuitive Surgical (ISRG) PT Raised to $750 at Canaccord Genuity; 'Hitting on All Cylinders'

Canaccord Genuity analyst Jason Mills reiterated a Buy rating and lifted his price target on Intuitive Surgical (NASDAQ: ISRG) to $750.00 (from $700.00) following strong results. Mills said the company is hitting on all cylinders and riding a tailwind with multiple levers still to pull.

Mills commented, "Viva la Robolucion! We made this proclamation coming out of the SAGES conference in March, repeated it after robust Q1 results, and reiterate it after the... More

Microsoft (MSFT) PT Raised to $62 at UBS Following Resilient Q4

UBS analyst Brent Thill reiterated a Buy rating and lifted his price target on Microsoft (NASDAQ: MSFT) to $62.00 (from $59.00) following better-than-expected Q4 results.

Thill commented, "Our 'grind higher' thesis remains intact as, after a tough FQ3, MSFT delivered a bounceback Q4, with total revenue $400M above Street ($22.6Bn, +5% CC), strong EPS upside boosted by a favourable tax rate ($0.69 vs. Street... More

Nomura Securities Reiterates Buy on Microsoft (MSFT) Following Solid 4Q

Nomura Securities reiterated a Buy rating and $65.00 price target on Microsoft (NASDAQ: MSFT) following the company's 4Q earnings report. Both revenues and EPS beat expectations. Microsoft guided to 1Q17 non-GAAP revenues of $21.2-21.9bn, below Street estimates at $22.2bn.

Analyst Frederick Grieb commented,... More